Why Select Medical (SEM) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are Investors Undervaluing Select Medical (SEM) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Select Medical To Spin-Off Concentra On November 25th
On November 06, Select Medical Holdings (NYSE: SEM; $40.20; Market Cap: $5.2 billion) announced a special stock distribution of its carved out unit Concentra Holdings (NYSE: CON; $19.67; Market Cap: $2.5 billion) to its shareholders. The distribution is set for November 25, 2024, with a record date of November 18, 2024.
Select Medical Up 13.8% Since Q3 Earnings Top on Patient Day Growth
SEM's strong third-quarter results benefit from improving patient days and admissions in the Rehabilitation Hospital segment. Elevated expenses partially offset the positives.
Here's Why Select Medical (SEM) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Select Medical Holdings Corporation (SEM) Q3 2024 Earnings Call Transcript
Select Medical Holdings Corporation (NYSE:SEM ) Q3 2024 Results Earnings Conference Call November 1, 2024 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman and Co-Founder Martin Jackson - Senior Executive Vice President of Strategic Finance and Operations Conference Call Participants Ben Hendrix - RBC Capital Markets Justin Bowers - Deutsche Bank William Sutherland - The Benchmark Company Christian Malachy Porter - Bank of America Securities Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to Discuss the Third Quarter 2024 Results and the Company's Business Outlook. Speaking today are the company's Executive Chairman and Co-Founder, Robert Ortenzio, and the company's Senior Executive Vice President of Strategic Finance and Operations, Martin Jackson.
Select Medical (SEM) Q3 Earnings and Revenues Surpass Estimates
Select Medical (SEM) came out with quarterly earnings of $0.50 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.46 per share a year ago.
Select Medical Holdings: No Reason To Downgrade This One Just Yet
Select Medical Holdings has shown strong performance, with shares up 48.7% since October 2023, outperforming the S&P 500's 37.3% increase. The company operates in a growing healthcare sector, with consistent revenue and profit growth across its Critical Illness Recovery, Rehabilitation, Outpatient Rehabilitation, and Concentra segments. Despite significant stock price appreciation, Select Medical Holdings remains attractively priced compared to similar businesses, justifying a continued 'buy' rating.
Select Medical Rises 50.2% YTD: Take Profits or Bet on More Gains?
SEM's profitability is being impacted by rising costs and expenses.
Select Medical Agrees to Acquire Valir Rehabilitation Hospital
SEM enters a definitive agreement to acquire Valir Rehabilitation Hospital and expand its inpatient rehabilitation footprint in Oklahoma City.
Select Medical's (SEM) Stock Down 16.9% Despite Q2 Earnings Beat
Select Medical (SEM) expects its adjusted EBITDA between $845 million and $885 million for 2024, the mid-point of which implies a 7.1% rise from the 2023 reported figure of $807.4 million.
Select Medical Holdings Corporation (SEM) Q2 2024 Earnings Call Transcript
Select Medical Holdings Corporation (NYSE:SEM ) Q2 2024 Earnings Call Transcript August 2, 2024 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman & Co-Founder Martin Jackson - Senior EVP of Strategic Finance and Operations Conference Call Participants Ben Hendrix - RBC Capital Markets A.J. Rice - UBS Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's earnings conference call to discuss the second quarter 2024 results and the Company's business outlook.
